<DOC>
	<DOCNO>NCT01169311</DOCNO>
	<brief_summary>Trial Objectives The primary objective clinical trial estimate Covidien EEAâ„¢ Hemorrhoid Prolapse Stapling Set : overall performance define successful creation normal staple line safety measure 30 day incidence adverse event .</brief_summary>
	<brief_title>Safety Performance Covidien EEA Hemorrhoid Prolapse Stapling Set Hemorrhoidopexy Procedure</brief_title>
	<detailed_description />
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Hemorrhoids</mesh_term>
	<criteria>Able understand sign Informed Consent Form The participant must 1880 year age . The participant ( symptomatic ) Grade 24 Hemorrhoids eligible staple hemorrhoidopexy . The procedure need revision hemorrhoid surgery . The participant pregnant . The participant active history infection require antibiotic intend operative site within thirty ( 30 ) day prior plan surgery date . The participant unable unwilling comply study requirement , followup schedule . The participant history drug alcohol abuse . The participant history venous thrombosis pulmonary embolism . The participant history coagulopathy . The participant take aspirin , anticoagulation and/or anti platelet therapy ( e.g . : Warfarin , Levonox ) within last 7 day prior plan surgery date The participant history fecal incontinence . The participant comorbidities , opinion investigator , appropriate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Hemorrhoids</keyword>
	<keyword>Hemorrhoid</keyword>
	<keyword>grade II , III , IV</keyword>
</DOC>